Online edition of India's National Newspaper
Wednesday, Nov 17, 2010
ePaper | Mobile/PDA Version
Google



Tamil Nadu
News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Retail Plus | Classifieds | Jobs | Obituary |

Tamil Nadu - Chennai Printer Friendly Page   Send this Article to a Friend

Radiation oncologists need to be guided by ethics: Shanta

Special Correspondent

“The availability of a high tech [gadget] should not be the reason for its use”

— Photo: R. Ragu

New facility:(From left) V. Shantha, chairperson, Cancer Institute, inaugurating the Nuclear Training Academy on Tuesday. Jonathan Briers (left) of Nucletron; M. Ravi, Additional Commissioner of Police, Traffic (right); and B. Viswanathan, MD, Nuclear Training Academy, are in the picture.

CHENNAI: Major technological advances in cancer diagnostics and therapeutics have, while significantly contributing to patient survival and quality of life, also raised important ethical issues on the clinical context that justifies the use of high-tech equipment, V. Shanta, Chairman, Adyar Cancer Institute said on Tuesday.

Inaugurating the Nucletron Indian Training Academy (NITA), a Dutch-aided training facility for radiation oncologists and medical physicists, Dr. Shanta said while there is no doubt that these have added to diagnostic capability, early detection, precision radiotherapy planning and survival, the advent of sophisticated technologies also raised issues such as which high-tech is essential, where it is to be used and what the cost-benefit is likely to be.

Calling upon radiation oncologists to be bound by codes of conduct and ethics, Dr. Shanta said practitioners needed to be guided by the outcome in deciding treatment options. “The availability of a high tech (gadget) should not be the reason for its use,” she said.

Dr. Shanta also called for self-appraisal focused on improved patient care, inculcation of Best Practices and advocacy of treatment decisions determined by efficacy of therapy, survival and quality of life.

Cost effectiveness

“As important (as these) will be cost effectiveness and cost benefit. Treatment must be affordable so that the fruits of research can reach everyone without distinctions,” she said.

M. Ravi, Additional Commissioner of Police (Traffic) said training and skills development were essential for any organisation.

Jonathan Briers, representing the Netherlands-headquartered company Nucletron, said the company aimed to move from providing products and services in radiation oncology to providing solutions.

Printer friendly page  
Send this article to Friends by E-Mail



Tamil Nadu

News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Retail Plus | Classifieds | Jobs | Obituary | Updates: Breaking News |


News Update



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | Publications | eBooks | Images | Ergo | Home |

Copyright © 2010, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu